Oxidation Phenotype and Beta-Blockers

This publication has 13 references indexed in Scilit:

• Oxidation Phenotype — A Major Determinant of Metoprolol Metabolism and Response
  New England Journal of Medicine, 1982
• Defective hydroxylation of bufuralol associated with side‐effects of the drug in poor metabolisers [letter]
  British Journal of Clinical Pharmacology, 1982
• Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
  Published by Wiley ,1982
• Variability of beta-blocker pharmacokinetics in young volunteers
  European Journal of Clinical Pharmacology, 1982
• The genetic controlof bufuralol metabolisminman
  European Journal of Drug Metabolism and Pharmacokinetics, 1982
• The effect of age on the pharmacokinetics of metoprolol and its metabolites.
  Published by Wiley ,1981
• A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol
  European Journal of Clinical Pharmacology, 1980
• Polymorphism of carbon oxidation of drugs and clinical implications.
  BMJ, 1978
• Comparison of plasma and saliva levels of metoprolol and oxprenolol.
  Published by Wiley ,1978
• Metabolism of metoprolol‐(³H) in man, the dog and the rat
  Acta Pharmacologica et Toxicologica, 1975